Surgical Glue Market: Market Size & Forecast 2026

Surgical glue, also known as surgical sealants and adhesives, is used across a wide range of surgical procedures including cardiovascular, orthopedic, general, and reconstructive surgery to seal tissues, control bleeding, and reduce the need for mechanical suturing. The global market is valued at approximately $4.09 billion in 2025 and is projected to grow at an 8.33% annual rate, with growth forecasts extending through 2031 to 2034 depending on the analysis framework. This expansion is driven by the shift toward less invasive procedures, the increasing number of surgeries performed worldwide, and clinical evidence showing that tissue adhesives can reduce operative time and improve patient outcomes compared to traditional closure methods.

• •The market covers surgical sealants and adhesives spanning natural, synthetic, and semi-synthetic material families
• •Valuations across industry sources for 2025 generally cluster between roughly $2.5 billion and $2.7 billion, with some analyses projecting higher depending on scope and segment inclusion
• •Growth is underpinned by rising surgical caseloads, aging demographics, and the transition toward minimally invasive and laparoscopic procedures

The increasing volume of surgical procedures globally, driven by aging populations, rising chronic disease burdens, and expanding access to healthcare in emerging markets, is a core engine of market growth. Minimally invasive and robotic-assisted surgeries, which favor the use of topical adhesives and sealants due to their ease of application in confined spaces, are accelerating adoption of surgical glue products. Advances in biomaterials have yielded next-generation adhesives with superior biocompatibility, controlled degradation profiles, and stronger tissue bonding, expanding the range of clinical applications and encouraging substitution of sutures and staples. Regulatory support for innovative hemostatic agents and growing surgeon familiarity with adhesive technology further reinforce the market's upward trajectory.

• •Aging populations and higher prevalence of chronic conditions such as cardiovascular disease and diabetes drive up surgical procedure rates worldwide
• •Minimally invasive and laparoscopic surgery adoption is expanding rapidly, particularly in ambulatory surgical centers and hospital outpatient departments
• •Product innovation, including bioabsorbable adhesives, improved hemostatic performance, and enhanced handling properties, broadens clinical utility and uptake

The market is segmented by product type, application, and end user. By material, categories include natural adhesives (fibrin-, collagen-, and gelatin-based), synthetic and semi-synthetic options (cyanoacrylates, polymeric hydrogels, urethane-based adhesives), and composite formulations. Application segments cover cardiovascular, orthopedic, general, plastic and reconstructive, and other surgical specialties, while end users include hospitals, ambulatory surgical centers, and specialty clinics. North America holds the largest market share, supported by advanced healthcare infrastructure, high surgical volumes, and favorable reimbursement environments. The Asia-Pacific region is widely recognized as the fastest-growing market, propelled by rising healthcare expenditure, increasing numbers of accredited hospitals, and growing medical tourism activity.

• •North America commands the largest market share due to high surgical adoption rates, established reimbursement frameworks, and strong presence of key manufacturers
• •Asia-Pacific is the most rapidly expanding region, driven by economic growth, healthcare infrastructure investment, and rising surgical demand across China, India, and Southeast Asia
• •Europe represents a significant mature market, with regulatory harmonization through CE marking facilitating product access and commercial rollout

What are the recent trends and outlook?

The market is moving toward bioabsorbable and hemostatic adhesive formulations designed to degrade naturally within the body, reducing the need for removal and minimizing long-term complications. Synthetic polymeric hydrogels and advanced cyanoacrylate derivatives are gaining share over older natural adhesive formulations due to improved mechanical properties and shelf stability. Demand for products with enhanced hemostatic performance, particularly in high-blood-loss procedures such as liver resection and cardiovascular surgery, is spurring R&D investment across the industry. Looking ahead, the convergence of biomaterials innovation, rising surgical complexity, and continued procedural volume growth positions the market for sustained expansion, with projections commonly reaching between roughly $2.9 billion and $5.0 billion by the early 2030s depending on scope and regional assumptions.

• •Bioabsorbable surgical adhesives that naturally degrade over time are a major product development focus, offering patient safety and convenience advantages
• •Synthetic and semi-synthetic adhesives, particularly polymeric hydrogels and next-generation cyanoacrylates, are displacing older natural formulations in several clinical applications
• •Regulatory approval trends and FDA/CE-marking requirements shape product launch timing and market entry strategies across manufacturers